LGVN קצב צמיחת רווח למניה בשנה הנוכחית Longeveron Inc.

Specialized cryogenic drug delivery supports margins, as evidenced by the annual EPS percentage change in the GURU.Markets chart, where 44.50 captures the current indicator value for Longeveron Inc. (LGVN). The development of treatments for age-related pathologies ensures long-term demand, although success depends on heart hypoplasia tests and the control of R&D costs.

This indicator reflects the rate of change in net earnings per share compared to the same period last year. By analyzing year-over-year earnings per share dynamics, an investor determines the trajectory of the business's operational efficiency. The metric captures the growth or decline rate of the real return on capital. For Longeveron Inc. (LGVN), such fluctuations are critical, as the development of cell therapy requires immense expenditures. A positive trend would confirm the commercial success of innovations in Alzheimer's treatment.